ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $656,250 | -31.9% | 120,413 | -21.3% | 0.00% | -25.0% |
| Q2 2023 | $964,200 | +66168.0% | 153,081 | -7.2% | 0.00% | -33.3% |
| Q1 2023 | $1,455 | +14.5% | 164,954 | -1.0% | 0.01% | 0.0% |
| Q4 2022 | $1,271 | -99.9% | 166,564 | -6.0% | 0.01% | -14.3% |
| Q3 2022 | $1,260,000 | -17.1% | 177,113 | -5.7% | 0.01% | -12.5% |
| Q2 2022 | $1,519,000 | -41.7% | 187,861 | -0.0% | 0.01% | -38.5% |
| Q1 2022 | $2,607,000 | -43.8% | 187,900 | +13.6% | 0.01% | -40.9% |
| Q4 2021 | $4,639,000 | +3.5% | 165,368 | +25.4% | 0.02% | -8.3% |
| Q3 2021 | $4,480,000 | -14.4% | 131,841 | +2.9% | 0.02% | -17.2% |
| Q2 2021 | $5,234,000 | -80.9% | 128,114 | -81.1% | 0.03% | -84.3% |
| Q1 2021 | $27,356,000 | +1037.0% | 679,563 | +1568.8% | 0.18% | +927.8% |
| Q4 2020 | $2,406,000 | +113.7% | 40,722 | +75.8% | 0.02% | +63.6% |
| Q3 2020 | $1,126,000 | +169.4% | 23,160 | +168.1% | 0.01% | +175.0% |
| Q2 2020 | $418,000 | +290.7% | 8,640 | +125.0% | 0.00% | +300.0% |
| Q1 2020 | $107,000 | +494.4% | 3,840 | +548.6% | 0.00% | – |
| Q4 2019 | $18,000 | -40.0% | 592 | -39.3% | 0.00% | – |
| Q3 2019 | $30,000 | – | 975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |